0460: Right heart involvement in patients with laminopathies  by Wahbi, Karim et al.
© Elsevier Masson SAS. All rights reserved.
 
26 Archives of Cardiovascular Diseases Supplements (2016) 8, 23-40
0460
Right heart involvement in patients with laminopathies
Karim Wahbi* (1), Guillaume Durand Viel (1), Rabah Ben Yaou (2),
Anthony Behin (2), Henri-Marc Bécane (2), Pascal Laforet (2), Tanya Sto-
jkovic (2), Bruno Eymard (2), Gisèle Bonne (2), Denis Duboc (2)
(1) APHP-Hôpital Cochin, Paris, France – (2) APHP-GH Pitié-Salpê-
trière, Paris, France
*Corresponding author: karim.wahbi@psl.aphp.fr (Karim Wahbi)
Introduction Laminopathies are rare genetic diseases, with various clinical
manifestations. Cardiac involvement may include conduction system disease,
supraventricular and ventricular arrhythmias, and dilated cardiomyopathy. In
other cardiac diseases, right ventricular dysfunction has been associated with an
impaired prognosis. 
Objective To study the prevalence of right ventricular involvement in lam-
inopathies and its influence on patient outcome.
Methods and results We retrospectively included 138 patients (age=37
[25-49], female=58%) with LMNA gene mutations. At baseline, conduction
system disease was present in 36% of patients, supraventricular arrhythmias in
25%, non-sustained and sustained ventricular tachyarrhythmias (VT) in 7 and
6%, left ventricular dysfunction in 42%. The association of right ventricular
systolic dysfunction and clinical signs of right heart failure was observed in
18 patients (13%) including 9 who presented with isolated right ventricular
without left ventricular systolic dysfunction. Over a 13.5 median follow-up
duration, 47 patients (34%) developed major cardiac adverse events, including
23 with end-stage heart failure, 28 with sustained VT, and 26 with 2nd degree
Mobitz II or 3rd degree AV blocks. Right ventricular involvement was signifi-
cantly associated with truncating mutations (44% vs. 22%, p=0.04), higher
global mortality (44% vs. 17%, p<0.001), end-stage heart failure (56% vs.
11%, p<0.001), sustained ventricular tachycardia (56% vs. 17%, p<0.001),
supraventricular tachyarrhythmias (94% vs. 49%, p<0.001), and sinus node
dysfunction (33% vs. 7%, p<0.001).
Conclusion Patients with laminopathies are at risk for right ventricular
dysfunction, which may be present without any left ventricular systolic dys-
function and frequently leads to end-stage heart failure. 
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Background The characteristics of DM1 patients with atrial flutter (AFL)
and their clinical outcome are unknown.
Methods We retrospectively included the patients ≥18 years of age with
DM1 who were admitted in our institutions with AFL between January 2000
and September 2013 and analyzed their clinical outcome. We compared the
incidence of AFL recurrences in patients who were treated with versus
without radiofrequency (RF) ablation. Single and multiple variable analyses
were performed to identify predictors of AFL recurrences.
Results We included 60 consecutive patients (age=41±13 years, male=34),
including 55 with persistent, 2 with paroxysmal, and 3 permanent AFL. Over
a 53±28 months mean follow-up duration, AFL recurrence occurred in 12
patients (24%), atrial fibrillation in 13 (26%), ischemic stroke in 2 (3%), cere-
bral hemorrhage in 1 (2%) and sinus node dysfunction in 4 (7%). Patients
treated by RF ablation were significantly more frequently free of AFL recur-
rences by Kaplan Meier analysis (95% vs. 61%, HR=0.17, 95% CI 0.08 to
0.97, p=0.04). By multivariate analyses, RF ablation was the only parameter
significantly associated with absence of AFL recurrence (p=0.01). 
Conclusions Patients with DM1 presenting with AFL are exposed to
stroke, severe sinus node dysfunction and cerebral hemorrhage. RF catheter
ablation is associated with a lower risk for AFL recurrences and may limit iat-
rogenic complications associated with pharmacological treatments.
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Aims Evaluate the factors presents at diagnosis associated to left ventric-
ular recovery in acute heart failure (AHF) revealing reduced left ventricular
ejection fraction (LVEF). 
Background A lot of paperwork have studied the left ventricular evolution
in chronic heart failure but not in AHF and indistinctly of LVEF. We don’t
know the predictive factors of left ventricular recovery in a specific population
of acute heart failure revealing reduced LVEF. 
Methods We conducted a prospective and observational longitudinal
study with retrospective data collection based on a cohort of patients with
acute heart failure revealing reduced LVEF (≤45%), in the emergency
department and cardiac intensive care unit (ED and CCIU) of the Univer-
sity Hospital of Lille, between November 1st, 2011 and May 31st, 2013.
The primary endpoint was the improvement of LVEF or left ventricular
reverse remodeling.
Results Among the 111 patients included, 57% of patients benefited from
an improvement of LVEF and 62% from a reverse remodeling in the 51% of
patients with a dilated left ventricle. The improvement of LVEF was associ-
ated in univariate analysis to non ischaemic etiology (p=0.002) and greater uti-
lization of betablockers (p=0.076) and angiotensin-converting enzyme
(p=0.0337) and in multivariate analysis, independtly to younger patients
(p=0.0325) and presentation by cardiogenic shock (p=0.0484). The same pre-
dictive factors were found for reverse remodeling.
Conclusion The knowledge of the prevalence and the early predictive fac-
tors of the left ventricular recovery can be useful to guide the follow-up and
non-pharmacological management of heart failure with reduced LVEF. 
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Introduction Heart failure experiencing exponential growth in Algeria.
Among the recommended therapeutic, the b blockers are largely under pre-
scribed. The objective of this study was to determine predicting factors of tol-
erance to carvedilol in systolic heart failure.
Patients and Methods Carvedilol has been introduced in 100 consecutive
patients hospitalized with systolic heart failure. Clinical parameters, the BNP
levels and echocardiographic indices were measured blind to admission to the
first and second week.
Results The average age of patients was 66±1 year. The FE: 31±1%, the
NYHA 2.8±0.1, BNP 620±48pg/mL, E/A: 1 8±0.3, TDE 160±7, E/E’,
9.1±0.3, PAPS: 36±0.4, VCI: 15+1mm. An acute decompensation episode
occurred in 21patients and b blocker was arrested at 9 of them without the
possibility of reintroduction. In univariate analysis, the values on admission
NYHA stage, the plasma level of BNP, the TDE and reports E/A and E/E’
